Search by Drug Name or NDC

    NDC 68462-0726-90 SAXAGLIPTIN 2.5 mg/1 Details

    SAXAGLIPTIN 2.5 mg/1

    SAXAGLIPTIN is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., USA. The primary component is SAXAGLIPTIN HYDROCHLORIDE.

    Product Information

    NDC 68462-0726
    Product ID 68462-726_e286ffd4-c598-47fb-af06-2e15f7e6f99f
    Associated GPIs
    GCN Sequence Number 065430
    GCN Sequence Number Description saxagliptin HCl TABLET 2.5 MG ORAL
    HIC3 C4J
    HIC3 Description ANTIHYPERGLYCEMIC, DPP-4 INHIBITORS
    GCN 27393
    HICL Sequence Number 036471
    HICL Sequence Number Description SAXAGLIPTIN HCL
    Brand/Generic Generic
    Proprietary Name SAXAGLIPTIN
    Proprietary Name Suffix n/a
    Non-Proprietary Name SAXAGLIPTIN
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 2.5
    Active Ingredient Units mg/1
    Substance Name SAXAGLIPTIN HYDROCHLORIDE
    Labeler Name Glenmark Pharmaceuticals Inc., USA
    Pharmaceutical Class Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA205994
    Listing Certified Through 2024-12-31

    Package

    NDC 68462-0726-90 (68462072690)

    NDC Package Code 68462-726-90
    Billing NDC 68462072690
    Package 90 TABLET, FILM COATED in 1 BOTTLE (68462-726-90)
    Marketing Start Date 2023-07-31
    NDC Exclude Flag N
    Pricing Information N/A